BRIEF published on 08/19/2024 at 13:35, 1 year 8 months ago Libsyn Announces Sale of Pair Networks, Leadership Transition Acquisition Leadership Transition Libsyn Pair Networks Podcasting
BRIEF published on 08/19/2024 at 13:35, 1 year 8 months ago Libsyn annonce la vente de Pair Networks et une transition de direction Acquisition Transition De Direction Libsyne Podcasting Réseaux De Paires
BRIEF published on 08/19/2024 at 13:25, 1 year 8 months ago MindBio Reports Sustained Antidepressant Response Post Microdosing Treatment Clinical Trials Microdosing LSD MindBio Therapeutics Mental Health Treatment Antidepressant Response
BRIEF published on 08/19/2024 at 13:25, 1 year 8 months ago MindBio rapporte une réponse antidépressive soutenue après un traitement par microdosage Essais Cliniques Microdosage Du LSD Traitement De Santé Mentale Thérapeutique MindBio Réponse Aux Antidépresseurs
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Ivanhoe Electric and Ma'aden Joint Venture Commences Drilling Activities in Saudi Arabia Saudi Arabia Drilling Ivanhoe Electric Ma'aden Typhoon™
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Ivanhoe Electric et Ma'aden Joint Venture lancent des activités de forage en Arabie Saoudite Forage Arabie Saoudite Ivanhoé Électrique Ma'aden Typhoon™
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago The Penco Module Advances to the Next Stage of Its Permitting Process Environmental Impact Assessment Aclara Resources Inc. Rare Earth Minerals Penco Module SEA And ICSARA
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Le module Penco passe à l'étape suivante de son processus d'autorisation Ressources Aclara Inc. Module Penco Évaluation De L'impact Environnemental Minéraux De Terres Rares Océanie Et Océanie-Caraïbes-Atlantique
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05 FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Tanvex BioPharma USA, Inc. franchit deux étapes réglementaires aux États-Unis : la FDA approuve Nypozi(TM) et la FDA accepte la demande de licence de produits biologiques biosimilaires pour le TX-05 Traitement Du Cancer Approbation De La FDA Biosimilaire Innovation Dans Le Domaine De La Santé Neutropénie
Published on 05/07/2026 at 14:35, 18 minutes ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 23 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 14:30, 23 minutes ago Loar Holdings Inc. Reports Q1 2026 Record Results and Upward Revision to 2026 Outlook
Published on 05/07/2026 at 14:00, 53 minutes ago Adcore to Publish First Quarter 2026 Results on May 14, 2026
Published on 05/07/2026 at 14:00, 53 minutes ago Metallic Minerals Announces Option Agreement with Argyle Resources on McKay Hill Property, Yukon
Published on 05/07/2026 at 14:30, 23 minutes ago More charging power than the grid connection can provide: Battery-buffered microgrid unlocks new potential for fast charging
Published on 05/07/2026 at 14:05, 48 minutes ago Addepar Introduces ADX, Enabling Data Activation and AI at Scale
Published on 05/07/2026 at 14:02, 50 minutes ago Genel Energy PLC: Results of Annual General Meeting 7 May 2026
Published on 05/07/2026 at 07:43, 7 hours 10 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 20 hours 53 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 20 hours 53 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 20 hours 53 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
